|
InnateDB Protein
|
IDBP-747725.3
|
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
|
Gene Symbol
|
LITAF
|
|
Protein Name
|
|
|
Synonyms
|
PIG7; SIMPLE; TP53I7;
|
|
Species
|
Homo sapiens
|
|
Ensembl Protein
|
ENSP00000459533
|
|
InnateDB Gene
|
IDBG-14752 (LITAF)
|
|
Protein Structure
|
|
| Function |
Probable role in regulating transcription of specific genes. May regulate through NFKB1 the expression of the CCL2/MCP-1 chemokine. May play a role in tumor necrosis factor alpha (TNF- alpha) gene expression.
|
| Subcellular Localization |
Lysosome membrane {ECO:0000269PubMed:11274176}; Peripheral membrane protein {ECO:0000269PubMed:11274176}; Cytoplasmic side {ECO:0000269PubMed:11274176}. Note=Associated with membranes of lysosomes.
|
| Disease Associations |
Charcot-Marie-Tooth disease 1C (CMT1C) [MIM:601098]: A dominant demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. {ECO:0000269PubMed:12525712, ECO:0000269PubMed:15776429, ECO:0000269PubMed:15786462}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=Defects in LITAF may be involved in extramammary Paget disease (EMPD) carcinogenesis. EMPD is a cancerous disease representing about 8% of all malignant skin cancers; it usually appears in the anogenital area and can be fatal by metastasizing to internal organs when left untreated for a long time. The clinical features are usually those of eczematous eruptions with weeping and crust formation.
|
| Tissue Specificity |
Ubiquitously and abundantly expressed. Expressed predominantly in the placenta, peripheral blood leukocytes, lymph nodes and spleen. {ECO:0000269PubMed:10200294, ECO:0000269PubMed:11274176}.
|
| Comments |
|
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 10 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
| Experimentally validated |
| Total |
10
[view]
|
| Protein-Protein |
9
[view]
|
| Protein-DNA |
1
[view]
|
| Protein-RNA |
0
|
| DNA-DNA |
0
|
| RNA-RNA |
0
|
| DNA-RNA |
0
|
|
| Predicted by orthology |
| Total |
3 [view]
|
|
|
Molecular Function |
|
| Biological Process |
|
| Cellular Component |
|
| PDB ID |
|
| InterPro |
IPR006629
LPS-induced tumor necrosis factor alpha factor
|
| PFAM |
PF10601
|
| PRINTS |
|
| PIRSF |
|
| SMART |
SM00714
|
| TIGRFAMs |
|
| Modification |
|
| SwissProt |
Q99732
|
| PhosphoSite |
PhosphoSite-Q99732
|
| TrEMBL |
I3L3U8
|
| UniProt Splice Variant |
|
| Entrez Gene |
9516
|
| UniGene |
Hs.561271
|
| RefSeq |
XP_006721046
|
| HUGO |
HGNC:16841
|
| OMIM |
603795
|
| CCDS |
CCDS32386
|
| HPRD |
10354
|
| IMGT |
|
| EMBL |
AB034747
AC007616
AC099489
AF010312
AK095955
BC000053
BC008309
BC016491
BC039840
BC046154
BC096063
BC096065
BC096066
BC101401
BC101402
BC101969
BX537543
CH471112
U77396
|
| GenPept |
AAB36550
AAC39530
AAH00053
AAH08309
AAH16491
AAH39840
AAH46154
AAH96063
AAH96065
AAH96066
AAI01402
AAI01403
AAI01970
BAB32547
CAD97778
EAW85150
EAW85151
EAW85152
EAW85153
|
|
|
|